This article contains online-exclusive supplemental material for Malik's article entitled, "Allogenic Versus Autologous Stem-Cell Therapy."
Nafees Malik
Advertisement
Articles by Nafees Malik
The author discusses potential manufacturing costs & challenges of allogeneic & autologous stem-cell therapy.
Eighty drugs will lose patent protection between 2007 and 2011.
Advertisement
Latest Updated Articles
Allogeneic Versus Autologous Stem-Cell TherapyJuly 1st 2012
Has the Era of Blockbuster Drugs Come to an End?December 1st 2007
Advertisement
Advertisement